Global Biopreservation Market Size, Trends & Forecast to 2033

Global Biopreservation Market Segmentation, By Product (Equipment, Media, LIMS), By Application (Regenerative Medicine, Bio-banking, Drug Discovery)- Industry Trends and Forecast to 2033

Global Biopreservation Market size was valued at USD 2.85 billion in 2025 and is expected to reach at USD 5.71 billion in 2033, with a CAGR of 7.2% during the forecast period of 2025 to 2033.

Global Biopreservation Market Overview

The global biopreservation market is experiencing significant growth, driven by increasing demand for the storage and preservation of biological materials such as cells, tissues, vaccines, and blood products. Advancements in cryopreservation, freeze-drying, and controlled rate freezing technologies enhance the stability and longevity of sensitive biomaterials, supporting research, clinical, and therapeutic applications. Rising investments in regenerative medicine, stem cell research, and biopharmaceutical development further propel market expansion. North America and Europe dominate due to established healthcare infrastructure and research funding, while Asia-Pacific is emerging rapidly with growing biobanking facilities and increasing adoption of advanced preservation techniques. The market’s growth is underpinned by the critical need for safe, long-term biological material storage.

Global Biopreservation Market Scope

Global Biopreservation Market Dynamics

The global biopreservation market is witnessing robust growth, driven by increasing demand for the safe storage and long-term preservation of biological materials, including cells, tissues, blood products, vaccines, and stem cells. Biopreservation technologies, such as cryopreservation, freeze-drying (lyophilization), vitrification, and controlled-rate freezing, are critical for maintaining the integrity, viability, and functionality of sensitive biomaterials. The growth of regenerative medicine, stem cell research, and biopharmaceutical development has significantly increased the need for advanced preservation solutions. Rising investments in clinical research, biobanking infrastructure, and the expansion of organ and tissue transplantation programs are further fueling market adoption. Additionally, the increasing prevalence of chronic diseases, rising demand for personalized medicine, and global emphasis on drug development and vaccine storage are key drivers supporting market growth.

Despite these positive trends, the market faces certain restraints, including high costs of preservation equipment and storage systems, technical complexity, and the need for skilled personnel to handle sensitive biological materials. Operational challenges such as maintaining optimal storage conditions, preventing contamination, and ensuring sample traceability also affect market efficiency.

Emerging markets in Asia-Pacific and Latin America offer significant opportunities due to growing research infrastructure, increased biopharmaceutical production, and expanding biobanks. Technological advancements, such as automated cryopreservation systems, ultra-low temperature freezers, and cloud-based sample management, are improving efficiency and reliability. Overall, the biopreservation market is poised for sustained growth, driven by rising healthcare research, advanced preservation technologies, and expanding applications in clinical and industrial biotechnology.

Global Biopreservation Market Segment Analysis

The global biopreservation market is segmented based on product types and applications, reflecting the diverse needs of research, clinical, and industrial biotechnology sectors. By product, the market includes equipment, media, and laboratory information management systems (LIMS). Equipment, such as cryopreservation freezers, liquid nitrogen storage tanks, controlled-rate freezers, and ultra-low temperature storage systems, represents the largest segment due to its critical role in maintaining the viability and integrity of biological samples. Media, including cryoprotectants, preservation solutions, and culture media, are essential for preventing cellular damage during freezing, storage, or transportation, supporting applications across regenerative medicine and biopharmaceutical research. Laboratory information management systems (LIMS) help manage, track, and store large volumes of biological samples in biobanks or research facilities, enhancing efficiency, traceability, and compliance with regulatory standards.

By application, the market is categorized into regenerative medicine, biobanking, and drug discovery. Regenerative medicine, including stem cell and tissue engineering research, is a key driver, as biopreservation ensures the long-term viability and functionality of cells and tissues for therapeutic applications. Biobanking involves large-scale storage of biological materials such as blood, tissues, and DNA for research, clinical diagnostics, and epidemiological studies, creating sustained demand for advanced preservation systems and solutions. In drug discovery, biopreservation supports preclinical and clinical research by enabling the secure storage of biological samples, cell lines, and experimental models for reproducibility and longitudinal studies.

Overall, the segment analysis highlights the market’s technological diversity and broad applicability, with equipment leading in revenue generation and regenerative medicine and biobanking emerging as high-growth application areas. The increasing adoption of automated storage systems, advanced cryoprotective media, and integrated LIMS solutions, combined with rising research investments globally, is expected to further expand biopreservation applications across healthcare, biotechnology, and pharmaceutical industries.

Global Biopreservation Market Regional Analysis

The global biopreservation market demonstrates significant regional variation, driven by research infrastructure, healthcare development, and technological adoption. North America dominates the market, led by the United States, due to well-established biotechnology and pharmaceutical industries, advanced laboratory infrastructure, and substantial investment in regenerative medicine, biobanking, and stem cell research. Europe follows closely, with countries such as Germany, the UK, and France investing heavily in research facilities, clinical laboratories, and regulatory-compliant biobanking solutions, supported by government funding and biosafety regulations. The Asia-Pacific region is emerging as the fastest-growing market, fueled by rapid expansion of research institutions, increasing healthcare investments, and rising adoption of advanced preservation technologies in countries like China, India, Japan, and South Korea. Latin America and the Middle East & Africa show moderate growth, driven by expanding healthcare infrastructure and emerging biobanking initiatives. Overall, while North America and Europe maintain market leadership, Asia-Pacific offers substantial growth opportunities for biopreservation equipment, media, and LIMS solutions.

Global Biopreservation Market Key Players

·         Thermo Fisher Scientific Inc.

·         BioLife Solutions, Inc

·         Chart Industries, Inc. (Cryoport Systems)

·         Merck KGaA

·         VWR International, LLC (part of Avantor)

·         Sigma-Aldrich Corporation (a subsidiary of Merck KGaA)

·         Brooks Life Sciences (now part of Azenta Life Sciences)

·         Biocision, LLC

·         Lifeline Scientific, Inc.

·         Cesca Therapeutics Inc.

Recent Developments

In April 2025, BioLife Solutions, Inc. acquired PanTHERA CryoSolutions, Inc., a developer of advanced cryopreservation media based on proprietary Ice Recrystallization Inhibitor (IRI) technology, enhancing BioLife’s biopreservation consumables and scientific expertise for cell and gene therapy workflows.

In October 2025, Cryoport, Inc. expanded its global infrastructure by opening a large temperature‑controlled supply chain facility in Louvres, France, improving logistics support for advanced therapies requiring biopreservation. Other industry players invested in expanding cryopreservation capabilities, including BioLife launching a new subsidiary focused on optimizing cryoprotectants in 2025.

Research Methodology

At Foreclaro Global Research, our research methodology is firmly rooted in a comprehensive and systematic approach to market research. We leverage a blend of reliable public and proprietary data sources, including industry reports, government publications, company filings, trade journals, investor presentations, and credible online databases. Our analysts critically evaluate and triangulate information to ensure accuracy, consistency, and depth of insights. We follow a top-down and bottom-up data modelling framework to estimate market sizes and forecasts, supplemented by competitive benchmarking and trend analysis. Each research output is tailored to client needs, backed by transparent data validation practices, and continuously refined to reflect dynamic market conditions.